SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-17-002944
Filing Date
2017-11-01
Accepted
2017-11-01 16:30:26
Documents
2
Period of Report
2017-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CLOVIS ONCOLOGY, INC. 8-K a51709463.htm 8-K 19169
2 EXHIBIT 99.1 a51709463ex99_1.htm EX-99.1 102619
  Complete submission text file 0001157523-17-002944.txt   122925
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35347 | Film No.: 171169347
SIC: 2834 Pharmaceutical Preparations